Quantcast

Latest Amyotrophic lateral sclerosis Stories

2014-07-17 23:01:11

Annual Fill the Boot Campaigns Heat Up This Summer; Events Nationwide Benefit Children and Adults Fighting Muscle Disease. CHICAGO, (PRWEB) July 17, 2014 The Muscular Dystrophy Association and the International Association of Fire Fighters (IAFF) are set to kick off another summer season of the fire fighters' spirited Fill the Boot campaign. Throughout 2014, the two organizations are celebrating 60 years of a partnership committed to saving and improving the lives of more than one...

2014-07-16 23:03:05

ReportsnReports.com adds “OpportunityAnalyzer Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2018” to its store. Patent Expiration of Rilutek to Cause Negative Growth in Amyotrophic Lateral Sclerosis Treatment Market by 2018. Dallas, TX (PRWEB) July 16, 2014 The amyotrophic lateral sclerosis (ALS) treatment market value will decline from $64 million in 2013 to $38 million by 2018, at a negative Compound Annual Growth Rate (CAGR) of 10.05%, according to...

2014-07-16 16:24:01

ABERDEEN, Scotland and SINGAPORE, July 16, 2014 /PRNewswire/ -- TauRx Therapeutics Ltd [http://www.taurx.com ] announced it has achieved its target enrollment of 833 subjects into one of its two ongoing multi-center Phase III clinical trials of LMTX(TM) [http://taurx.com/lmtx-for-ad ], a tau aggregation inhibitor, for the treatment of Alzheimer's Disease [AD]. This placebo-controlled clinical trial (Protocol TRx-237-015 [http://taurx.com/015-clinical-study.html ]) has...

2014-07-16 08:29:14

--Interim Results Show NUEDEXTA Provides Meaningful Reduction of PBA Episodes and is Generally Well Tolerated in Alzheimer's Disease/Dementia Population-- ALISO VIEJO, Calif., July 16, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced interim data from the phase IV PRISM II study showing that treatment with NUEDEXTA(®) substantially reduced symptoms of pseudobulbar affect (PBA) in patients with Alzheimer's disease/dementia. PBA is a distressing neurologic...

2014-07-09 23:03:30

The Parkinson’s Disease and Parkinsonism Caregiver Symposium will be held on July 12. Tiburon, CA (PRWEB) July 09, 2014 Living Well Assisted Living at Home is proud to announce that they will be joining the 2014 Caregiver Events organized by the Stanford PD Caregiver Support Program. Dr. Doris Bersing, president and CEO of Living Well Assisted Living, will present on suggestions for how to improve family dynamics around Parkinson’s individuals through positive communication at the...

2014-07-08 10:03:49

King's College London Scientists have identified a set of 10 proteins in the blood which can predict the onset of Alzheimer's, marking a significant step towards developing a blood test for the disease Scientists have identified a set of 10 proteins in the blood which can predict the onset of Alzheimer's, marking a significant step towards developing a blood test for the disease. The study, led by King's College London and UK proteomics company, Proteome Sciences plc, analysed over...

2014-07-02 12:20:39

The JAMA Network Journals Use of exome sequencing improved the ability to identify the underlying gene mutations in patients with biochemically defined defects affecting multiple mitochondrial respiratory chain complexes (enzymes that are involved in basic energy production), according to a study in the July 2 issue of JAMA. Defects of the mitochondrial respiratory chain have emerged as the most common cause of childhood and adult neurometabolic disease, with an estimated prevalence of...

burrowing frog
2014-07-01 03:45:29

Society for Experimental Biology Scientists at the University of Queensland, Australia, have identified key genes that help burrowing frogs avoid muscle wastage whilst they are dormant. These genetic insights could help prevent muscle atrophy in bedridden human patients, or even astronauts. For most mammals, including humans, when muscles are inactive over a long period, they lose condition and waste away. However, some animals can remain dormant for several months and yet suffer...

2014-06-30 20:22:37

ALISO VIEJO, Calif., June 30, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that data related to pseudobulbar affect (PBA), a neurological condition characterized by disruptive, uncontrollable episodes of laughing or crying, and NUEDEXTA® (dextromethorphan hydrobromide/quinidine sulfate), the only FDA-approved product for the treatment of PBA, will be presented at the Alzheimer's Association International Conference (AAIC), being held at the Bela...

2014-06-29 12:21:03

WASHINGTON, June 29, 2014 /PRNewswire-USNewswire/ -- In work supported by The ALS Association, researchers have shown that increasing the clearance of misfolded protein from neurons improves their survival. The study was published today in the journal Nature Chemical Biology. http://photos.prnewswire.com/prnvar/20131211/MM32178LOGO ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects motor neurons (nerve...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related